Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma Group. 1989

W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
Christie Hospital, Manchester, U.K.

UI MeSH Term Description Entries
D008297 Male Males
D008741 Methyl Methanesulfonate An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA. Methylmethane Sulfonate,Dimethylsulfonate,Mesilate, Methyl,Methyl Mesylate,Methyl Methylenesulfonate,Methylmesilate,Mesylate, Methyl,Methanesulfonate, Methyl,Methyl Mesilate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D012509 Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. Sarcoma, Epithelioid,Sarcoma, Soft Tissue,Sarcoma, Spindle Cell,Epithelioid Sarcoma,Epithelioid Sarcomas,Sarcomas,Sarcomas, Epithelioid,Sarcomas, Soft Tissue,Sarcomas, Spindle Cell,Soft Tissue Sarcoma,Soft Tissue Sarcomas,Spindle Cell Sarcoma,Spindle Cell Sarcomas

Related Publications

W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
March 2002, European journal of cancer (Oxford, England : 1990),
W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
July 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
January 1993, European journal of cancer (Oxford, England : 1990),
W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
March 1999, European journal of cancer (Oxford, England : 1990),
W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
December 1989, European journal of cancer & clinical oncology,
W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
October 1987, European journal of cancer & clinical oncology,
W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
May 1987, European journal of cancer & clinical oncology,
W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
January 1981, Cancer treatment reports,
W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
January 2000, European journal of cancer (Oxford, England : 1990),
W P Steward, and H T Mouridsen, and P Kerbrat, and R Somers, and J Verweij, and A T Van Oosterom, and G Blackledge, and H Havsteen, and D Thomas, and R Sylvester
January 1992, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!